Krensavage Asset Management, LLC
CIK:0001609251
Hedge Fund
$221M AUM
15 holdings
New York, NY, US
Krensavage Asset Management, LLC is a hedge fund manager headquartered in New York, NY, United States. The firm manages equity portfolios primarily for institutional investors and high-net-worth individuals. Founded in 2002 by Michael Krensavage, it focuses on deep fundamental research, primarily within the healthcare, biotechnology, and pharmaceutical sectors. The employee count appears to be under 20.
Investment Strategy
Krensavage Asset Management employs a value-oriented, long/short equity strategy focusing on small- and mid-cap companies, particularly in healthcare and pharmaceuticals. The firm uses deep fundamental research to identify undervalued companies with catalysts for revaluation, combining concentrated positions with active risk management.
Top Buys
J
JNJJOHNSON & JOHNSON+$6.1M
I
INDVINDIVIOR PLC+$5.2M
J
JAZZJAZZ PHARMACEUTICALS PLC+$5.0M
E
ENTAENANTA PHARMACEUTICALS INC+$4.3M
R
REGNREGENERON PHARMACEUTICALS+$2.1M
Top Sells
E
EXELEXELIXIS INC-$10.7M
C
CAHCARDINAL HEALTH INC-$3.5M
U
UTHRUNITED THERAPEUTICS CORP-$1.2M
S
SNYSANOFI-ADR-$1.1M
A
AVDLAVADEL PHARMACEUTICALS+$1.0M
Top Holdings
U
UTHRUNITED THERAPEUTICS CORP+15.4%$29.1M
C
CAHCARDINAL HEALTH INC+11.9%$22.5M
E
EXELEXELIXIS INC+11.5%$21.8M
J
JAZZJAZZ PHARMACEUTICALS PLC+9.3%$17.5M
E
ENTAENANTA PHARMACEUTICALS INC+8.5%$16.0M
Equity Positions (15)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
U UTHR | UNITED THERAPEUTICS CORP | 15.38% | $29.1M | 101,146 | $135.12 | $287.35 | -$1.2M |
C CAH | CARDINAL HEALTH INC | 11.89% | $22.5M | 133,745 | $60.19 | $168.00 | -$3.5M |
E EXEL | EXELIXIS INC | 11.51% | $21.8M | 493,526 | $19.09 | $44.08 | -$10.7M |
J JAZZ | JAZZ PHARMACEUTICALS PLC | 9.26% | $17.5M | 164,816 | $115.61 | $106.12 | +$5.0M |
E ENTA | ENANTA PHARMACEUTICALS INC | 8.46% | $16.0M | 2,114,444 | $20.19 | $7.56 | +$4.3M |
Industry Allocation
PHARMACEUTICAL PREPARATIONS
+72.5%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+15.6%
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
+11.9%